Contact
searchSearch
HMP Global
Login

Access Support Resource Center

Featured

News
Improving Health Care Access for Immigrants With Disabilities in North America
03/14/2025
Hannah Musick
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and...
03/14/2025
Journal of Clinical Pathways
News
Strategies to Enhance Cancer Screening Access for Patients With Disabilities
03/06/2025
Juliet Gallagher
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face...
03/06/2025
Journal of Clinical Pathways
News
Large Language Models Aid in Simplifying Clinical Trial Information for Patients
02/19/2025
Grace Taylor, MS, MA
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how...
02/19/2025
Journal of Clinical Pathways
News
Study Identifies Gaps and Opportunities in Community Engagement at Cancer Centers
01/22/2025
Juliet Gallagher
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer...
01/22/2025
Journal of Clinical Pathways
News
Social Risks Lower Rates of Preventive Cancer Screenings
01/09/2025
Juliet Gallagher
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI...
01/09/2025
Journal of Clinical Pathways
News
Travel and Financial Burdens Play a Role in Cancer Care
12/19/2024
Jolynn Tumolo
The joint stressors of travel burdens and financial hardship can affect the care patients with cancer receive.
The joint stressors of travel burdens and financial hardship can affect the care patients with cancer receive.
The joint stressors of travel...
12/19/2024
Journal of Clinical Pathways
News
Addressing Racial and Ethnic Disparities in Cancer Clinical Trial Access
12/06/2024
Juliet Gallagher
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements,...
12/06/2024
Journal of Clinical Pathways
News
Under 50% of Oncology Practices Offer Survivorship Clinics
11/12/2024
Jolynn Tumolo
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice...
11/12/2024
Journal of Clinical Pathways
Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
News
US Cancer Centers Still Struggling with Chemotherapy Shortages, NCCN’s Recent Survey Reveals
11/04/2023
Brandon Twyford
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent...
11/04/2023
Journal of Clinical Pathways

News

News
Improving Health Care Access for Immigrants With Disabilities in North America
03/14/2025
Hannah Musick
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and...
03/14/2025
Journal of Clinical Pathways
News
Strategies to Enhance Cancer Screening Access for Patients With Disabilities
03/06/2025
Juliet Gallagher
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face...
03/06/2025
Journal of Clinical Pathways
News
Large Language Models Aid in Simplifying Clinical Trial Information for Patients
02/19/2025
Grace Taylor, MS, MA
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how...
02/19/2025
Journal of Clinical Pathways
News
Study Identifies Gaps and Opportunities in Community Engagement at Cancer Centers
01/22/2025
Juliet Gallagher
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer...
01/22/2025
Journal of Clinical Pathways
News
Social Risks Lower Rates of Preventive Cancer Screenings
01/09/2025
Juliet Gallagher
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI...
01/09/2025
Journal of Clinical Pathways
News
Travel and Financial Burdens Play a Role in Cancer Care
12/19/2024
Jolynn Tumolo
The joint stressors of travel burdens and financial hardship can affect the care patients with cancer receive.
The joint stressors of travel burdens and financial hardship can affect the care patients with cancer receive.
The joint stressors of travel...
12/19/2024
Journal of Clinical Pathways
News
Addressing Racial and Ethnic Disparities in Cancer Clinical Trial Access
12/06/2024
Juliet Gallagher
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements,...
12/06/2024
Journal of Clinical Pathways
News
Under 50% of Oncology Practices Offer Survivorship Clinics
11/12/2024
Jolynn Tumolo
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice...
11/12/2024
Journal of Clinical Pathways
News
GE HealthCare Introduces New Precision Care Tools to Expand Access to Personalized Medicine
06/10/2024
Grace Taylor, MS, MA
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare premiered its new precision care tools to expand the practice of more personalized medicine internationally.
General Electric (GE) HealthCare...
06/10/2024
Journal of Clinical Pathways
News
US Cancer Centers Still Struggling with Chemotherapy Shortages, NCCN’s Recent Survey Reveals
11/04/2023
Brandon Twyford
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent...
11/04/2023
Journal of Clinical Pathways
News
Academic Cancer Centers Improve Outcomes for Patients With Mantle Cell Lymphoma
03/18/2025
Lisa Kuhns, PhD, MD
Patients with mantle cell lymphoma (MCL) who receive treatment at academic cancer centers experience longer overall survival and higher participation in clinical trials compared to those treated in community-based practices, according to a...
Patients with mantle cell lymphoma (MCL) who receive treatment at academic cancer centers experience longer overall survival and higher participation in clinical trials compared to those treated in community-based practices, according to a...
Patients with mantle cell...
03/18/2025
Journal of Clinical Pathways
News
Improving Health Care Access for Immigrants With Disabilities in North America
03/14/2025
Hannah Musick
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and...
03/14/2025
Journal of Clinical Pathways
News
AI Revolutionizes Early Detection and Diagnosis of Gastric Cancer
03/14/2025
Lisa Kuhns, PhD, MD
Artificial intelligence (AI) is rapidly transforming the landscape of early gastric cancer (EGC) detection and treatment, offering promising solutions to improve diagnostic accuracy, treatment planning, and patient outcomes, according to an...
Artificial intelligence (AI) is rapidly transforming the landscape of early gastric cancer (EGC) detection and treatment, offering promising solutions to improve diagnostic accuracy, treatment planning, and patient outcomes, according to an...
Artificial intelligence (AI) is...
03/14/2025
Journal of Clinical Pathways
News
Oral JAK2 Inhibitor Offers a Viable Second-Line Treatment for Myelofibrosis, but Challenges Remain
03/13/2025
Lisa Kuhns, PhD, MD
Fedratinib, an oral JAK2 inhibitor, has demonstrated efficacy in treating myelofibrosis (MF), particularly in patients who have failed ruxolitinib therapy, according to a study published in the Blood Cancer Journal.
Fedratinib, an oral JAK2 inhibitor, has demonstrated efficacy in treating myelofibrosis (MF), particularly in patients who have failed ruxolitinib therapy, according to a study published in the Blood Cancer Journal.
Fedratinib, an oral JAK2...
03/13/2025
Journal of Clinical Pathways
News
Early Measurable Residual Disease Assessment Predicts Survival in Patients With Mantle Cell Lymphoma
03/12/2025
Lisa Kuhns, PhD, MD
Patients with mantle cell lymphoma (MCL) can benefit from measurable residual disease (MRD) assessment during induction therapy, with the timing and kinetics of MRD negativity significantly impacting prognosis and treatment strategies,...
Patients with mantle cell lymphoma (MCL) can benefit from measurable residual disease (MRD) assessment during induction therapy, with the timing and kinetics of MRD negativity significantly impacting prognosis and treatment strategies,...
Patients with mantle cell...
03/12/2025
Journal of Clinical Pathways
News
Radiomics and AI Advance NSCLC Staging Precision
03/10/2025
Juliet Gallagher
A recent study published in Cancers explores the potential of artificial intelligence (AI) to enhance the preliminary staging of non-small cell lung cancer (NSCLC) using computed tomography (CT) imaging.
A recent study published in Cancers explores the potential of artificial intelligence (AI) to enhance the preliminary staging of non-small cell lung cancer (NSCLC) using computed tomography (CT) imaging.
A recent study published in...
03/10/2025
Journal of Clinical Pathways
News
Evaluating the Cost Benefits and Clinical Potential of Serum Pepsinogen Screening for Gastric Cancer
03/07/2025
Juliet Gallagher
A recent study published in Gastro Hep Advances evaluated the cost-effectiveness of using serum pepsinogen (PG) screening for the early detection of gastric cancer (GC) in the US.
A recent study published in Gastro Hep Advances evaluated the cost-effectiveness of using serum pepsinogen (PG) screening for the early detection of gastric cancer (GC) in the US.
A recent study published in...
03/07/2025
Journal of Clinical Pathways
News
Strategies to Enhance Cancer Screening Access for Patients With Disabilities
03/06/2025
Juliet Gallagher
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face...
03/06/2025
Journal of Clinical Pathways
News
Machine Learning Identifies Key Genomic Markers to Predict CPI Outcomes in NSCLC
03/06/2025
Grace Taylor, MS, MA
A machine learning-driven study analyzing genomic data from patients with non-small cell lung cancer (NSCLC) reveals specific mutations and pathways that influence resistance to checkpoint inhibitor immunotherapy, offering potential targets...
A machine learning-driven study analyzing genomic data from patients with non-small cell lung cancer (NSCLC) reveals specific mutations and pathways that influence resistance to checkpoint inhibitor immunotherapy, offering potential targets...
A machine learning-driven study...
03/06/2025
Journal of Clinical Pathways
News
Ruxolitinib Prior to Transplantation Linked to Better Survival in Myelofibrosis
03/05/2025
Grace Taylor, MS, MA
Pre-transplant use of ruxolitinib may enhance survival outcomes for patients with myelofibrosis undergoing stem cell transplantation.
Pre-transplant use of ruxolitinib may enhance survival outcomes for patients with myelofibrosis undergoing stem cell transplantation.
Pre-transplant use of...
03/05/2025
Journal of Clinical Pathways

Interviews

Lee Fleisher, MD
Interview
CMS National Quality Strategy Focuses on Quality, Safety, Affordability Standards in Oncology Care
11/10/2022
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the...
11/10/2022
Journal of Clinical Pathways
Overcoming Resource, Reimbursement Barriers to Comprehensive Cancer Care Delivery
Interview
Overcoming Resource, Reimbursement Barriers to Comprehensive Cancer Care Delivery
07/10/2020
At the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program(May 29-31, 2020), the Association of Community Cancer Centers (ACCC) presented the preliminary results of a member survey on...
At the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program(May 29-31, 2020), the Association of Community Cancer Centers (ACCC) presented the preliminary results of a member survey on...
At the...
07/10/2020
Journal of Clinical Pathways
Houda Hachad, PharmD
Interview
FDA Highlights Risks Associated With DPD Deficiency, Advises Testing Before Treatment
03/26/2025
Houda Hachad, PharmD
This interview explores the US Food and Drug Administration’s (FDA) updated guidance on dihydropyrimidine dehydrogenase (DPD) deficiency and its implications for improving patient safety through pre-treatment DPYD testing before...
This interview explores the US Food and Drug Administration’s (FDA) updated guidance on dihydropyrimidine dehydrogenase (DPD) deficiency and its implications for improving patient safety through pre-treatment DPYD testing before...
This interview explores the US...
03/26/2025
Journal of Clinical Pathways
Upal Basu Roy, PhD, MPH
Interview
Project PRIORITY: Elevating the Patient Voice in EGFR-Positive NSCLC Care
03/24/2025
Upal Basu Roy, PhD, MPH
In this interview, Upal Basu Roy, PhD, MPH, shares how by centering on patient experiences, Project PRIORITY reveals critical disparities in access to diagnostics, treatment, and palliative care for patients with epidermal growth factor...
In this interview, Upal Basu Roy, PhD, MPH, shares how by centering on patient experiences, Project PRIORITY reveals critical disparities in access to diagnostics, treatment, and palliative care for patients with epidermal growth factor...
In this interview, Upal Basu...
03/24/2025
Journal of Clinical Pathways
Kohli Headshot
Interview
Strengthening Patient Pathways With BIS for Lymphedema Surveillance
03/24/2025
Manpreet Kohli, MD
In this interview, Manpreet Kohli, MD, discusses the incorporation of bioimpedance spectroscopy into NAPBC standards, the impact of early lymphedema detection on survivorship, and how clinicians can better support patient-centered care...
In this interview, Manpreet Kohli, MD, discusses the incorporation of bioimpedance spectroscopy into NAPBC standards, the impact of early lymphedema detection on survivorship, and how clinicians can better support patient-centered care...
In this interview, Manpreet...
03/24/2025
Journal of Clinical Pathways
Chelsea Renfro, PharmD
Interview
How Integrated Health System Pharmacies Enhance Treatment Adherence and Adverse Effect Management for CLL
03/21/2025
Houston Wyatt, PharmD; Chelsea E. Renfro, PharmD; Stephanie White, PharmD
This interview explores how integrated health system pharmacy services can improve medication adherence, persistence, and adverse effect management in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
This interview explores how integrated health system pharmacy services can improve medication adherence, persistence, and adverse effect management in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
This interview explores how...
03/21/2025
Journal of Clinical Pathways
Graf Headshot
Interview
The Future of Chronic Lymphocytic Leukemia Management with Targeted Therapies
03/17/2025
In this interview, an expert discusses the preclinical development and clinical impact of zanubrutinib in chronic lymphocytic leukemia, highlighting key findings from pivotal trials, comparisons with other therapies, and future research...
In this interview, an expert discusses the preclinical development and clinical impact of zanubrutinib in chronic lymphocytic leukemia, highlighting key findings from pivotal trials, comparisons with other therapies, and future research...
In this interview, an expert...
03/17/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 2
03/17/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology...
03/17/2025
Journal of Clinical Pathways
Brian S.
Interview
Key Advancements in Immunotherapy for Endometrial Cancer
03/13/2025
Brian M. Slomovitz, MD, MS
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses...
03/13/2025
Journal of Clinical Pathways
Brufsky Headshot
Interview
Transforming Metastatic Breast Cancer Care With AI and Real-World Evidence
03/11/2025
Adam Brufsky, MD, PhD
In this interview, Adam Brufsky, MD, PhD, discusses the evolving treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer, the impact of CDK4/6 inhibitors, the role of genomic assays and artificial intelligence...
In this interview, Adam Brufsky, MD, PhD, discusses the evolving treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer, the impact of CDK4/6 inhibitors, the role of genomic assays and artificial intelligence...
In this interview, Adam Brufsky,...
03/11/2025
Journal of Clinical Pathways
Interview
Strategies to Expand Access to Genomic Testing for Patients With NSCLC
03/07/2025
Anne S. Tsao, MD, MBA, FASCO, FACHE
In this interview, Anne S. Tsao, MD, MBA, FASCO, FACHE, discusses the challenges of managing resistance to EGFR-targeted therapies in non-small cell lung cancer and highlights emerging strategies to overcome treatment resistance.
In this interview, Anne S. Tsao, MD, MBA, FASCO, FACHE, discusses the challenges of managing resistance to EGFR-targeted therapies in non-small cell lung cancer and highlights emerging strategies to overcome treatment resistance.
In this interview, Anne S. Tsao,...
03/07/2025
Journal of Clinical Pathways
Kalinsky Headshot
Interview
Personalizing Adjuvant Therapy: Insights on Biomarkers, CDK4/6 Inhibitors, and Immunotherapy
03/04/2025
Kevin Kalinsky, MD, MS
In this interview, Kevin Kalinsky, MD, MS, discusses the evolving role of biomarkers, genomic assays, novel therapies, and precision medicine in early breast cancer treatment, highlighting the impact of CDK4/6 inhibitors, immunotherapy,...
In this interview, Kevin Kalinsky, MD, MS, discusses the evolving role of biomarkers, genomic assays, novel therapies, and precision medicine in early breast cancer treatment, highlighting the impact of CDK4/6 inhibitors, immunotherapy,...
In this interview, Kevin...
03/04/2025
Journal of Clinical Pathways

Blog

Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
Tom Valuck, MD, JD; Jacqlyn Riposo, MBA
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
David Blaisdell, BA; Tom Valuck, MD, JD; Sarena Ho, MSPH
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Bridget Doherty, MPH, MS; Silas Martin, MS; Tom Valuck, MD, JD
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
Winston Wong, PharmD
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Tom Valuck, MD, JD
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
Tom Valuck, MD, JD; Erik Muther; Theresa Schmidt, MA, PMP, CSPO; Danny Bellet, MBA; Donna Dugan, PhD, MS; David Sloan, PhD
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
Tom Valuck, MD, JD; Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
David Blaisdell, BA; Tom Valuck, MD, JD
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
Tom Valuck, MD, JD; Jacqlyn Riposo, MBA
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Winston Wong
Editor Insights
A Look Back at Clinical Pathways in 2022
02/21/2023
Winston Wong, PharmD
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal...
02/21/2023
Journal of Clinical Pathways

Videos

Laura Bray
Videos
Advocacy to Reduce the Impact of Drug Shortages on Cancer Care
07/23/2024
Laura Bray, MBA
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her experience as a patient advocate with Angels of Change and the key drivers impacting drug shortages.
Laura Bray, MBA, talks about her...
07/23/2024
Journal of Clinical Pathways
Video preview image.
Videos
St. Elizabeth’s Innovative Cancer Screening Outreach Model
09/22/2023
Michael Gieske, MD; Jamie Ries, BSN, RN
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Puneeth Indurlal, MD
Videos
Impact of Dose Rounding Bevacizumab and its Biosimilars on Total Cost of Care for OCM Participants
07/26/2023
Puneeth Indurlal, MD
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses...
07/26/2023
Journal of Clinical Pathways
Monica Schmidt, PhD.
Videos
The Impact of Elsevier ClinicalPath Oncology Treatment Pathways on Survival and Cost of Care
07/24/2023
Monica Schmidt, PhD
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal...
07/24/2023
Journal of Clinical Pathways
Aaron P. Mitchell, MD, MPH
Videos
Study Examines the Association Between Oncologists’ Receipt of Pharmaceutical Industry Payments and Use of Nonrecommended/Low-Value Treatments
07/20/2023
Aaron P. Mitchell, MD
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH,...
07/20/2023
Journal of Clinical Pathways
Patricia Santos, MD
Videos
Health Care Access and Affordability for Adult Immigrant Cancer Survivors
06/26/2023
Patricia Santos, MD
Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...
Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...
Patricia Santos, MD, Memorial...
06/26/2023
Journal of Clinical Pathways
Lalan Wilfong, MD.
Conference Coverage
Benefits and Challenges of the Enhancing Oncology Model
06/13/2023
At the ASCO 2023 Annual Meeting, Lalan Wilfong, MD, provided an overview of the Enhancing Oncology Model and how it differs from and improves upon the Oncology Care Model.
At the ASCO 2023 Annual Meeting, Lalan Wilfong, MD, provided an overview of the Enhancing Oncology Model and how it differs from and improves upon the Oncology Care Model.
At the ASCO 2023 Annual Meeting,...
06/13/2023
Journal of Clinical Pathways
Dr Daniel Virnich, President, the Oncology Institute.
Videos
A Value-based Framework for Drug Cost Support and Funding Programs
05/11/2023
Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.
Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.
Dr Daniel Virnich, President,...
05/11/2023
Journal of Clinical Pathways
Adria Warren, Partner at Foley & Lardner LLP
Videos
New Developments in the 340B Drug Pricing Program
04/03/2023
Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...
Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...
Adria Warren, health care...
04/03/2023
Journal of Clinical Pathways
Lee Fleisher, MD
Videos
Making Clinical Pathways Unique to the Patient Journey
11/14/2022
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses...
11/14/2022
Journal of Clinical Pathways
Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
03/24/2025
F. Randy Vogenberg, PhD, FASHP
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
03/24/2025
Journal of Clinical Pathways
Videos
Progress and Unmet Needs in Post-IO Treatment for Metastatic RCC
03/19/2025
Neil Shah, MD
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah...
03/19/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 2
03/17/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology...
03/17/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 1
03/11/2025
Gordon Kuntz; Carole Tremonti, RN, MBA
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts Gordon Kuntz and Carole Tremonti, RN, MBA, discuss the goals, challenges, and collaborative efforts of the Predictable Cost of Care Working Group, highlighting its role in developing a standardized model for...
In this interview, experts...
03/11/2025
Journal of Clinical Pathways
Zibelman Headshot
Videos
Exploring the Potential of Nivolumab and Axitinib in Renal Cell Carcinoma
03/11/2025
Matthew Zibelman, MD
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares results from his study on combination systemic therapy with tyrosine kinase inhibitor nivolumab and immune checkpoint inhibitor axitinib for patients with metastatic renal cell carcinoma.
Matthew Zibelman, MD, shares...
03/11/2025
Journal of Clinical Pathways
BDHC Thumbnail
Videos
Expanding Access to Clinical Trials: What Oncologists and Payers Need to Know
02/28/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down...
02/28/2025
Cancer Care Business Exchange
Videos
Why Pathways Matter: Editorial Advisory Board Testimonials
02/28/2025
Alan J. Balch, PhD, MSc
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal of Clinical Pathways has been at the forefront of advancing evidence-based, value-driven care through clinical pathways. As we celebrate our 10th anniversary, we’re highlighting the voices of key thought leaders...
For the past 10 years, Journal...
02/28/2025
Journal of Clinical Pathways
Doshi Headshot
Videos
Assessing Real-World Outcomes of First-Line Ipilimumab and Nivolumab for Advanced Renal Cell Carcinoma
02/18/2025
Sahil Doshi, MD
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi, MD, discusses the outcomes of a recent trial he authored on first-line ipilimumab and nivolumab for metastatic renal cell carcinoma, highlighting its implications for clinical practice and payer considerations.
In this interview, Sahil Doshi,...
02/18/2025
Journal of Clinical Pathways
Headshot
Videos
The Role of ctDNA Clearance in RCC: Retrospective Analysis and Clinical Implications
02/13/2025
Adanma Ayanambakkam, MD
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma Ayanambakkam, MD, discusses his study on the use of circulating tumor DNA (ctDNA) clearance as a biomarker in renal cell carcinoma (RCC), highlighting findings from a single-institution retrospective study and its...
In this interview, Adanma...
02/13/2025
Journal of Clinical Pathways
Houda Hachad, PharmD
Videos
Implementing PGx Testing in Oncology: Best Practices, Barriers, and Benefits
02/12/2025
Houda Hachad, PharmD
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.
Houda Hachad, PharmD, highlights...
02/12/2025
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Recent Stories

News
Improving Health Care Access for Immigrants With Disabilities in North America
03/14/2025
Hannah Musick
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and...
03/14/2025
Journal of Clinical Pathways
News
Strategies to Enhance Cancer Screening Access for Patients With Disabilities
03/06/2025
Juliet Gallagher
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face significant barriers to cancer screening, including communication challenges, physical inaccessibility, financial constraints, and provider assumptions, highlighting the need for targeted interventions to...
Patients with disabilities face...
03/06/2025
Journal of Clinical Pathways
News
Large Language Models Aid in Simplifying Clinical Trial Information for Patients
02/19/2025
Grace Taylor, MS, MA
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how artificial intelligence can generate accurate, patient-friendly summaries of cancer clinical trials, potentially improving enrollment and adherence.
A recent study explores how...
02/19/2025
Journal of Clinical Pathways
News
Study Identifies Gaps and Opportunities in Community Engagement at Cancer Centers
01/22/2025
Juliet Gallagher
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer Spectrum highlights the challenges and opportunities for improving the impact of Community Outreach and Engagement (COE) programs at National Cancer Institute (NCI)-designated cancer centers.
A study published in JNCI Cancer...
01/22/2025
Journal of Clinical Pathways
News
Social Risks Lower Rates of Preventive Cancer Screenings
01/09/2025
Juliet Gallagher
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI Cancer Spectrum investigated the pathways through which social risks affect screening outcomes for breast, cervical, and colorectal cancer (CRC) in patients served in community-based clinics across the US.
A recent study published in JNCI...
01/09/2025
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use